The authors concluded that undetectable faecal Hb may be sufficient to exclude CRC/IBD/higher-risk adenomas with 41.7 % test negatives, 96.2 % NPV and 88.2 % sensitivity – thereby questioning the added value of calprotectin, as in our study. The gene discussed is GSTM1; the disease is colorectal carcinoma.